The effects of calcium-based versus non-calcium-based phosphate binders on mortality among patients with chronic

Sophie A Jamal1, David Fitchett, Charmaine E Lok

  • 1University of Toronto, Division of Endocrinology and Metabolism, Women's College Hospital, Toronto, Canada.

Insights

Non-calcium phosphate binders showed a trend toward lower mortality in chronic kidney disease patients. However, significant differences in cardiovascular events or vascular calcification were not found, necessitating further research.

Area of Science:

  • Nephrology
  • Cardiovascular Medicine
  • Pharmacology

Background:

  • The comparative effects of calcium-based versus non-calcium-based phosphate binders on patient outcomes in chronic kidney disease (CKD) remain unclear.
  • Key outcomes of interest include mortality, cardiovascular events, and vascular calcification.

Purpose of the Study:

  • To systematically review and analyze the available evidence comparing calcium-based and non-calcium-based phosphate binders in CKD patients.
  • To assess the impact of these binders on mortality, cardiovascular events, and vascular calcification.

Main Methods:

  • A systematic review was performed using electronic searches of major biomedical databases (MEDLINE, EMBASE, Cochrane, CINAHL).
  • Included were 8 randomized trials involving 2873 patients, identified through predefined criteria.
  • Data extraction and analysis were conducted systematically.

Main Results:

  • A trend towards decreased all-cause mortality was observed with non-calcium-based binders (RR 0.68; 95% CI 0.41-1.11).
  • No statistically significant difference was found for cardiovascular events (RR 0.85; 95% CI 0.35-2.03).
  • Analysis of coronary artery calcification showed a non-significant trend favoring non-calcium-based binders (change in calcium score: -76.35; 95% CI -158.25-5.55).

Conclusions:

  • While trends suggest potential benefits of non-calcium-based phosphate binders, statistically significant differences were not established for mortality, cardiovascular events, or coronary artery calcification.
  • The current evidence is limited by the small number of studies and sample sizes.
  • Further randomized trials are warranted to definitively assess the comparative efficacy and safety of these agents.
Abstract

Related Concept Videos

Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
Hormones and Bone Tissue01:17

Hormones and Bone Tissue

The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Skeleton and Calcium Homeostasis01:21

Skeleton and Calcium Homeostasis

Calcium is not only the most abundant mineral in bone but also the most abundant mineral in the human body. Calcium ions are needed for bone mineralization, tooth health, heart rate regulation and strength of contraction, blood coagulation, the contraction of smooth and skeletal muscle cells, and the regulation of nerve impulse conduction. The average calcium level in the blood is about 10 mg/dL. When the body cannot maintain this level, a person will experience hypo or hypercalcemia.
Chronic Kidney Disease IV: Nursing Management01:18

Chronic Kidney Disease IV: Nursing Management

Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of fluid...